Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design
- PMID: 23095896
- PMCID: PMC6268209
- DOI: 10.3390/molecules171112533
Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design
Abstract
Cystine-knot peptides display exceptional structural, thermal, and biological stability. Their eponymous motif consists of six cysteine residues that form three disulfide bonds, resulting in a notably rigid structural core. Since they highly tolerate either rational or combinatorial changes in their primary structure, cystine knots are considered to be promising frameworks for the development of peptide-based pharmaceuticals. Despite their relatively small size (two to three dozens amino acid residues), the chemical synthesis route is challenging since it involves critical steps such as head-to-tail cyclization and oxidative folding towards the respective bioactive isomer. Herein we describe the topology of cystine-knot peptides, their synthetic availability and briefly discuss potential applications of engineered variants in diagnostics and therapy.
Figures





Similar articles
-
Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.PLoS One. 2013 Oct 11;8(10):e76956. doi: 10.1371/journal.pone.0076956. eCollection 2013. PLoS One. 2013. PMID: 24146945 Free PMC article.
-
Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.Adv Exp Med Biol. 2016;917:121-44. doi: 10.1007/978-3-319-32805-8_7. Adv Exp Med Biol. 2016. PMID: 27236555 Review.
-
Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.Curr Opin Pharmacol. 2009 Oct;9(5):608-14. doi: 10.1016/j.coph.2009.05.004. Epub 2009 Jun 10. Curr Opin Pharmacol. 2009. PMID: 19523876 Review.
-
Fragmentation follows structure: top-down mass spectrometry elucidates the topology of engineered cystine-knot miniproteins.PLoS One. 2014 Oct 10;9(10):e108626. doi: 10.1371/journal.pone.0108626. eCollection 2014. PLoS One. 2014. PMID: 25303319 Free PMC article.
-
Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions.Chembiochem. 2013 Jan 2;14(1):137-46. doi: 10.1002/cbic.201200604. Epub 2012 Dec 11. Chembiochem. 2013. PMID: 23229141
Cited by
-
Peptide aptamers: development and applications.Curr Top Med Chem. 2015;15(12):1082-101. doi: 10.2174/1568026615666150413153143. Curr Top Med Chem. 2015. PMID: 25866267 Free PMC article. Review.
-
A Chemical Biology Approach to Probing the Folding Pathways of the Inhibitory Cystine Knot (ICK) Peptide ProTx-II.Front Chem. 2020 Apr 3;8:228. doi: 10.3389/fchem.2020.00228. eCollection 2020. Front Chem. 2020. PMID: 32309273 Free PMC article.
-
Chemical Synthesis and Functional Analysis of VarvA Cyclotide.Molecules. 2018 Apr 19;23(4):952. doi: 10.3390/molecules23040952. Molecules. 2018. PMID: 29671790 Free PMC article.
-
Ultra-High-Throughput Screening of Cystine-Rich Peptide Libraries Via Yeast Surface Display.Methods Mol Biol. 2025;2934:275-291. doi: 10.1007/978-1-0716-4578-9_18. Methods Mol Biol. 2025. PMID: 40663336
-
Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.PLoS One. 2013 Oct 11;8(10):e76956. doi: 10.1371/journal.pone.0076956. eCollection 2013. PLoS One. 2013. PMID: 24146945 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources